HALO Halozyme Therapeutics, Inc.

[greencat]

HALO with a very nive move and makes a higher high. But not really and entry for me because its moved to far. Thats not to say that it may move farther up. I would like to see a consolidation before I jump in.
•Halozyme narrows 4Q loss due to Hylenex payment
HALO: Summary for Halozyme Therapeutics, Inc.- Yahoo! Finance

HALO Chart



Halozyme Therapeutics, Inc.
11388 Sorrento Valley Road
San Diego, CA 92121
United States - Map
Phone: 858-794-8889
Fax: 858-704-8311
Web Site: Halozyme Therapeutics - Halozyme is a biopharmaceutical company developing and commercializing products based on the extracellular matrix for the drug delivery, oncology, and dermatology markets.

DETAILS
Index Membership: N/A
Sector: Healthcare
Industry: Biotechnology
Full Time Employees: 129


BUSINESS SUMMARY
Halozyme Therapeutics, Inc., a biopharmaceutical company, engages in the development and commercialization of products targeting the extracellular matrix for the endocrinology, oncology, dermatology, and drug delivery markets. Its portfolio of products and product candidates is based on intellectual property covering the family of human enzymes known as hyaluronidases and additional enzymes that affect the extracellular matrix. The company’s Enhanze technology is a novel drug delivery platform designed to increase the absorption and dispersion of biologics. It has partnerships with F. Hoffmann-La Roche, Ltd and Hoffmann-La Roche, Inc. to apply Enhanze Technology to Roche’s biological therapeutic compounds for up to 13 targets; and with Baxter Healthcare Corporation to apply Enhanze Technology to Baxter’s biological therapeutic compound, GAMMAGARD LIQUID, as well as to develop and supply active pharmaceutical ingredient for HYLENEX, a product used as an adjuvant to increase the dispersion and absorption of other injected drugs and fluids. The company was founded in 1998 and is based in San Diego, California.